Mereo BioPharma Group plc (MPH.L) (LON:MPH – Get Free Report) crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 26.50 ($0.33) and traded as low as GBX 26 ($0.32). Mereo BioPharma Group plc (MPH.L) shares last traded at GBX 26.50 ($0.33), with a volume of 49,264 shares changing hands.
Mereo BioPharma Group plc (MPH.L) Price Performance
The company has a debt-to-equity ratio of 164.26, a current ratio of 2.98 and a quick ratio of 2.92. The company has a market capitalization of £89.76 million and a P/E ratio of -0.21. The firm’s 50-day moving average is GBX 26.50 and its 200-day moving average is GBX 26.50.
About Mereo BioPharma Group plc (MPH.L)
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.
Featured Stories
- Five stocks we like better than Mereo BioPharma Group plc (MPH.L)
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- United Airlines Soars on Earnings Beat
- Using the MarketBeat Stock Split Calculator
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.
